- Issuer ticker
-
GLSI
- Reported as of
-
13 Nov 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
17 Nov 2025, 06:05:39 UTC
Filing notes and source
Key filing fact
Snehal Patel filed Form 4 for Greenwich LifeSciences, Inc. (GLSI) on 17 Nov 2025.
Key facts
- This page summarizes Snehal Patel's Form 4 filing for Greenwich LifeSciences, Inc. (GLSI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Nov 2025, 06:05.
Change
- Previous filing in this sequence was filed on 12 Nov 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001806920
Primary reporting owner
Patel Snehal
- Relationship
-
CEO and CFO, Director, 10%+ Owner
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GLSI
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- +4.4%
- Price
-
$0.000000
- Shares after
- 2,347,462
- Date
- 13 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $8.20
* marks a reported price that did not pass the local price check.